Revvity expects 2%-3% organic growth and $5.35-$5.45 EPS for 2026 with Signals Xynthetica AI launch
Source: SeekingAlpha
2026-02-02 12:31:29 ET
More on Revvity
- Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
- Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Revvity expects to report Q4 revenue of $772 million
- Revvity trades higher on earnings guidance above consensus
Read the full article on Seeking Alpha
For further details see:
Revvity expects 2%–3% organic growth and $5.35–$5.45 EPS for 2026 with Signals Xynthetica AI launch
Revvity Inc.
NASDAQ: RVTY
RVTY Trading
1.46% G/L:
$86.0175 Last:
607,040 Volume:
$86.67 Open:
RVTY Latest News
February 05, 2026 08:00:00 am
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
RVTY Stock Data
$11,876,096,300
112,241,865
0.04%
224
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
